核酸サンプル調製市場：製品、用途、エンドユーザー別-世界予測2025-2030年

核酸サンプル調製市場は、2023年に45億2,000万米ドルと評価され、2024年には50億3,000万米ドルに達すると予測され、CAGR 9.11％で成長し、2030年には83億2,000万米ドルに達すると予測されています。

核酸サンプル調製は、様々な生物学的サンプルからDNAやRNAを抽出・精製することであり、診断学、ゲノミクス、個別化医療における下流工程のアプリケーションにとって極めて重要なステップです。このプロセスの必要性は、シーケンシング技術、ポリメラーゼ連鎖反応（PCR）、その他の分析手順において正確な結果を得るために不可欠な高品質の核酸を提供する能力にあります。その用途は、研究室、臨床診断、製薬、バイオテクノロジー分野に及ぶ。この市場の成長は、ゲノム技術の進歩、研究開発資金の増加、遺伝性疾患や感染症の有病率の上昇によって推進されています。しかし、先端技術のコスト高、規制上の制約、技術力などの課題が市場成長の妨げになる可能性があります。

成長に影響を与える主な要因としては、スループットと精度を向上させるサンプル調製システムの自動化導入の増加、小型化とスピードアップを可能にするマイクロ流体技術の統合などが挙げられます。新たなビジネスチャンスは、ポイントオブケア検査用のユーザーフレンドリーなキットや、ラボオンチップデバイスのようなポータブルソリューションの開発にあり、分散型アプリケーションや現場固有のアプリケーションに対応しています。企業は、費用対効果が高く高出力の技術を生み出すために研究開発に投資することで、こうした機会を活用することができます。とはいえ、市場関係者は、厳しい規制状況や急速に進化する技術への適応の必要性といった課題を乗り越えなければならないです。

技術革新と研究は、持続可能で環境に優しいアプローチの開発とともに、サンプル調製技術の効率と汎用性の向上に焦点を当てるべきです。さらに、人工知能との相乗効果を探ることで、ワークフロー管理とデータ解析を最適化し、競合優位性を提供することができます。核酸サンプル調製市場の性質はダイナミックで競争的であり、急速な技術進歩と進化する顧客要件を特徴としています。企業は、成長促進要因を活用するために機敏な情報収集を怠らない一方で、制約要因にも積極的に対処し、持続可能な発展と市場での確固たるポジショニングを確保する必要があります。

市場力学：急速に進化する核酸サンプル調製市場の主要市場インサイトを公開

核酸サンプル調製市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の感染症流行
  • 治療分野における核酸分子の使用拡大
• 市場抑制要因
  • 検出試薬に関連する高コスト、医療専門家に対する標準化されたトレーニングの欠如
• 市場機会
  • 自動核酸抽出技術の採用拡大
  • 核酸サンプル調製における新技術の進歩
• 市場の課題
  • 核酸サンプルに関連する倫理的懸念

ポーターのファイブフォース：核酸サンプル調製市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、核酸サンプル調製市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：核酸サンプル調製市場における外部からの影響の把握

外部マクロ環境要因は、核酸サンプル調製市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析核酸サンプル調製市場における競合情勢の把握

核酸サンプル調製市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス核酸サンプル調製市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、核酸サンプル調製市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨核酸サンプル調製市場における成功への道筋を描く

核酸サンプル調製市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で感染症の蔓延が増加
    • 治療分野における核酸分子の利用拡大
  • 抑制要因
    • 検出試薬のコストが高く、医療専門家向けの標準化されたトレーニングが不足している
  • 機会
    • 自動化された核酸抽出技術の採用の増加
    • 核酸サンプル調製における新たな技術的進歩
  • 課題
    • 核酸サンプルに関連する倫理的懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 核酸サンプル調製市場：製品別

• アクセサリー
• 消耗品
• サンプル調製機器

第7章 核酸サンプル調製市場：用途別

• エピゲノミクス
• ゲノミクス
• プロテオミクス

第8章 核酸サンプル調製市場：エンドユーザー別

• 学術・調査機関
• 臨床および診断研究室
• 製薬・バイオテクノロジー企業

第9章 南北アメリカの核酸サンプル調製市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の核酸サンプル調製市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの核酸サンプル調製市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• Aurora Biomed Inc.
• BGI Group
• Bio-Rad Laboratories, Inc.
• Bionano Genomics
• BIONEER CORPORATION
• Blue-Ray Biotech Corp.
• Danaher Corporation
• Eppendorf SE
• F. Hoffmann-La Roche Ltd
• Hamilton Company
• Illumina, Inc.
• LGC Biosearch Technologies
• Merck KGaA
• MP Biomedicals, LLC
• Nanjing Vazyme Biotech Co.,Ltd.
• Norgen Biotek Corp.
• Opentrons Labworks, Inc.
• PerkinElmer Inc.
• Promega Corporation
• QIAGEN N.V.
• RevoluGen Ltd
• Sansure Biotech Inc.
• Tecan Trading AG
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. NUCLEIC ACID SAMPLE PREPARATION MARKET RESEARCH PROCESS
• FIGURE 2. NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. NUCLEIC ACID SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. NUCLEIC ACID SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NUCLEIC ACID SAMPLE PREPARATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NUCLEIC ACID SAMPLE PREPARATION MARKET DYNAMICS
• TABLE 7. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SAMPLE PREPARATION INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY EPIGENOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. CANADA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. CANADA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. CANADA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. CHINA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. CHINA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. CHINA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. INDIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. INDIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. ITALY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. ITALY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. ITALY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. POLAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. POLAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. POLAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. QATAR NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. QATAR NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. QATAR NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. NUCLEIC ACID SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. NUCLEIC ACID SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2023

The Nucleic Acid Sample Preparation Market was valued at USD 4.52 billion in 2023, expected to reach USD 5.03 billion in 2024, and is projected to grow at a CAGR of 9.11%, to USD 8.32 billion by 2030.

Nucleic acid sample preparation involves the extraction and purification of DNA or RNA from various biological samples, a crucial step for downstream applications in diagnostics, genomics, and personalized medicine. The necessity of this process lies in its ability to provide high-quality nucleic acids, essential for accurate results in sequencing technologies, polymerase chain reactions (PCR), and other analytical procedures. Its application spans research laboratories, clinical diagnostics, pharmaceuticals, and biotechnology sectors. The growth of this market is propelled by advancements in genomic technologies, increased funding for research and development, and the rising prevalence of genetic disorders and infectious diseases. However, challenges such as high costs of advanced technologies, regulatory constraints, and technical competencies may hinder market growth.

Key influencing growth factors include the increased adoption of automation in sample preparation systems, which enhances throughput and accuracy, and the integration of microfluidic technologies that enable miniaturization and speed. Emerging opportunities lie in the development of user-friendly kits for point-of-care testing and portable solutions like lab-on-a-chip devices, catering to decentralized and field-specific applications. Companies can capitalize on these opportunities by investing in R&D to create cost-effective and high-output technologies. Nonetheless, market players must navigate challenges such as strict regulatory landscapes and the need for adaptation to rapidly evolving technologies.

Innovation and research should focus on improving the efficiency and versatility of sample preparation techniques, alongside developing sustainable and eco-friendly approaches. Additionally, exploring synergies with artificial intelligence can optimize workflow management and data analysis, offering competitive advantages. The nature of the nucleic acid sample preparation market is dynamic and competitive, characterized by rapid technological advancements and evolving customer requirements. Businesses must remain agile and informed to capitalize on growth drivers while proactively addressing constraints, ensuring sustainable development and robust market positioning.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Nucleic Acid Sample Preparation Market

The Nucleic Acid Sample Preparation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of infectious disease worldwide
  • Growing use of nucleic acid molecule in therapeutic areas
• Market Restraints
  • High cost associated with detection reagent and lack of standardized training for health professional
• Market Opportunities
  • Growing adoption of automated nucleic acid extraction techniques
  • New technological advancements in nucleic acid sample preparation
• Market Challenges
  • Ethical concerns associated with nucleic acid sample

Porter's Five Forces: A Strategic Tool for Navigating the Nucleic Acid Sample Preparation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Nucleic Acid Sample Preparation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Nucleic Acid Sample Preparation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Nucleic Acid Sample Preparation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Nucleic Acid Sample Preparation Market

A detailed market share analysis in the Nucleic Acid Sample Preparation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Nucleic Acid Sample Preparation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Nucleic Acid Sample Preparation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Nucleic Acid Sample Preparation Market

A strategic analysis of the Nucleic Acid Sample Preparation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Nucleic Acid Sample Preparation Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Aurora Biomed Inc., BGI Group, Bio-Rad Laboratories, Inc., Bionano Genomics, BIONEER CORPORATION, Blue-Ray Biotech Corp., Danaher Corporation, Eppendorf SE, F. Hoffmann-La Roche Ltd, Hamilton Company, Illumina, Inc., LGC Biosearch Technologies, Merck KGaA, MP Biomedicals, LLC, Nanjing Vazyme Biotech Co.,Ltd., Norgen Biotek Corp., Opentrons Labworks, Inc., PerkinElmer Inc., Promega Corporation, QIAGEN N.V., RevoluGen Ltd, Sansure Biotech Inc., Tecan Trading AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Nucleic Acid Sample Preparation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Accessories, Consumables, and Sample Preparation Instruments.
• Based on Application, market is studied across Epigenomics, Genomics, and Proteomics.
• Based on End-user, market is studied across Academic & Research Institutions, Clinical & Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of infectious disease worldwide
    • 5.1.1.2. Growing use of nucleic acid molecule in therapeutic areas
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with detection reagent and lack of standardized training for health professional
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing adoption of automated nucleic acid extraction techniques
    • 5.1.3.2. New technological advancements in nucleic acid sample preparation
  • 5.1.4. Challenges
    • 5.1.4.1. Ethical concerns associated with nucleic acid sample
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Nucleic Acid Sample Preparation Market, by Product

• 6.1. Introduction
• 6.2. Accessories
• 6.3. Consumables
• 6.4. Sample Preparation Instruments

7. Nucleic Acid Sample Preparation Market, by Application

• 7.1. Introduction
• 7.2. Epigenomics
• 7.3. Genomics
• 7.4. Proteomics

8. Nucleic Acid Sample Preparation Market, by End-user

• 8.1. Introduction
• 8.2. Academic & Research Institutions
• 8.3. Clinical & Diagnostic Laboratories
• 8.4. Pharmaceutical & Biotechnology Companies

9. Americas Nucleic Acid Sample Preparation Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Nucleic Acid Sample Preparation Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Nucleic Acid Sample Preparation Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Aurora Biomed Inc.
• 3. BGI Group
• 4. Bio-Rad Laboratories, Inc.
• 5. Bionano Genomics
• 6. BIONEER CORPORATION
• 7. Blue-Ray Biotech Corp.
• 8. Danaher Corporation
• 9. Eppendorf SE
• 10. F. Hoffmann-La Roche Ltd
• 11. Hamilton Company
• 12. Illumina, Inc.
• 13. LGC Biosearch Technologies
• 14. Merck KGaA
• 15. MP Biomedicals, LLC
• 16. Nanjing Vazyme Biotech Co.,Ltd.
• 17. Norgen Biotek Corp.
• 18. Opentrons Labworks, Inc.
• 19. PerkinElmer Inc.
• 20. Promega Corporation
• 21. QIAGEN N.V.
• 22. RevoluGen Ltd
• 23. Sansure Biotech Inc.
• 24. Tecan Trading AG
• 25. Thermo Fisher Scientific Inc.